Jan 27, 2023 / 11:00AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Q3 FY23 earnings call of Glenmark Life Sciences. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Ms. Soumi Rao. Thank you, and over to you, ma'am.
Soumi Rao - Glenmark Pharmaceuticals Ltd. - Corporate Communications & CSR
Good evening, everyone. I welcome you all to the earnings conference call of Glenmark Life Sciences Limited for the quarter ended December 31, 2022.
From Glenmark Pharmaceuticals Ltd., today, we have with us Dr. Yasir Rawjee, our MD and CEO; and Mr. Tushar Mistry, our CFO.
Our Board has approved the results for the quarter ended December 31, 2022. We have released the same to the stock exchanges and updated it on our website. Please note that the recording and the transcript of this call will be available on the website of the company.
Now, I'd like to draw your attention to the fact that some of the information shared as part of this call, especially information with respect to our plans and
Q3 2023 Glenmark Life Sciences Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot